Infectious Disease Dynamics | Infectious Disease Dynamics

Skip to main content

Projects

Fluscape Characterizing the immune landscapes of human influenza in southern China.
Cross-Sectional Incidence Testing Developing and validating testing algorithms to generate point estimates of HIV and HCV incidence.
COVID-19 Our multi-faceted project focuses on response to the current COVID-19 coronavirus pandemic. The areas of interest range from health intervention tracking to contact tracing app development.
HIV Dynamics We conduct highly interdisciplinary HIV research focused on the application of mechanistic models and molecular epidemiology to population-based cross-sectional and longitudinal survey data. Our efforts are largely concentrated in Sub-Saharan Africa.
Phylogenetic Study Design Developing methods to estimate informative sample sizes for phylogenetic studies.
Impetus The Impetus study aims to develop and extend statistical and modeling methodologies for spatial data.
Emerging Diseases Dynamic modeling and real time analyses to respond to emerging disease threats.
Healthcare Epidemiology We work closely with the Johns Hopkins Hospital and other organizations to understand and combat healthcare acquired infections.
Cholera Dynamics The Cholera Dynamics Project aims to study cholera transmission dynamics through mechanistic and statistical models using global incidence data.
Measles & Rubella Dynamics Working towards control, elimination, and eradication of two of the world's most infectious diseases.

Latest @JHIDDynamics

1 day 1 hour ago

RT @datcummings: Our review of antibody immunity to coronaviruses out today. https://t.co/YmqPhyxMa5 Hard work by @HuangAngkanaT BG… https://t.co/pKYCeYr3UH
3 days 1 hour ago

RT @isabelrodbar: Thrilled to share that my MIRA R35 was funded by @NIGMS! Will be recruiting postdocs to work on seroepidemiology an… https://t.co/EKSChqIVwc
1 week 11 hours ago

RT @JustinLessler: We had two preprints out last week. They might seem unrelated, but have lots to do with each other. In this thread… https://t.co/XZIM9L3Jve
2 weeks 6 days ago

RT @JustinLessler: While I 100% agree with @DrTomFriden's skepticism about herd immunity kicking in at 20-30%, the logic of this state… https://t.co/xEme9OFTs2
3 weeks 1 day ago

RT @PostOpinions: We don’t need to reach herd immunity to begin to get the virus under control, @JustinLessler writes in… https://t.co/3xHkT33q1y
3 weeks 1 day ago

RT @Ymax: Our global data collection for #npis is ongoing and we are still recruiting volunteers. Now more than ever it is cr… https://t.co/YFaoF9qaAq
3 weeks 1 day ago

RT @JustinLessler: Herd immunity is a journey, not a destination. My thoughts in @washingtonpost. https://t.co/BTiisEJryA
3 weeks 3 days ago

RT @IDDjobs: CLOSING SOON: Multiple Postdocs (Baltimore, United States) Cholera dynamics, including epidemiology, serology, sequ… https://t.co/R1phIBrC41
3 weeks 3 days ago

RT @SRileyIDD: No, that's not what the evidence says. Most people would interpret "less deadly" as a lower chance of death if you… https://t.co/rKSF8vDTB1
4 weeks 9 hours ago

RT @mlipsitch: Great advice. The strategy of head down and struggling alone is encouraged (unfortunately) at earlier stages but a… https://t.co/EtFSh0HYdb
1 month 2 days ago

Congrats to @shirleewohl on the results of months of hard work. https://t.co/dHAxMxlaP6
1 month 2 weeks ago

RT @JustinLessler: There are diseases to fight besides COVID, and strategies that might "win". A multi institutional collaboration led… https://t.co/20bRMSDLhL